Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early detection and treatment a ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Prostate cancer continues to disproportionately affect Black men at higher rates than other ... Understanding these overlooked risks becomes crucial for early detection and prevention strategies.

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Researchers analyzed data from two major prostate cancer prevention trials, linking them with Medicare health records to track outcomes for over 29,000 participants. Among these, nearly 4,000 men ...

A majority of prostate cancer deaths occurred among men with higher genetic risk, accounting for 88% of deaths by age 75 years. Lifestyle changes could prevent 22% to 36% of these deaths before ...

The aim of the PROBASE* study is to develop a prostate cancer screening strategy that significantly reduces the problem of overdiagnosis. Based on PROBASE data, scientists at the German Cancer ...

A possible strategy was signaled by secondary analyses of other Phase III trials. With evidence of PC reduction with vitamin E and selenium in lung cancer 48 and skin cancer 81 prevention trials, ...

To improve genetic screening for men with advanced prostate cancer, Cheng, with UW colleague Bruce Montgomery, MD, initiated the GENTleMEN study (GENetic Testing for MEN with prostate cancer). “[We ...